- Therapeutic Cataract & Refractive
- Lens Technology
- Glasses
- Ptosis
- AMD
- COVID-19
- DME
- Ocular Surface Disease
- Optic Relief
- Geographic Atrophy
- Cornea
- Conjunctivitis
- LASIK
- Myopia
- Presbyopia
- Allergy
- Nutrition
- Pediatrics
- Retina
- Cataract
- Contact Lenses
- Lid and Lash
- Dry Eye
- Glaucoma
- Refractive Surgery
- Comanagement
- Blepharitis
- OCT
- Patient Care
- Diabetic Eye Disease
- Technology
Dry Eye and Demodex Blepharitis Treatment Protocol
Ben Gaddie, OD, FAAO closes this series discussing his treatment protocol for patients with demodex blepharitis, reflecting on the major treatment advancements that can quickly alleviate patient symptoms.
Summary
In the conclusion of this series, Ben Gaddie, OD, FAAO outlines his protocol for treating demodex blepharitis, highlighting multiple treatment routs for care. Gaddie, OD, FAAO reflects on the efficacy of newer agents, which have demonstrated statistical significance in two weeks. This marks a leap forward in care, where previous treatments often required three to six months to see results. Gaddie underscores his belief in the importance of the SPEED score as a foundational tool to track symptoms over time. He closes by emphasizing the importance of tailoring treatments based on the individual patient's needs.
